DFCON21: Diabetic Foot Global Conference

Please visit the DFCON website for program information.

On October 21-23, 2021, the 21st edition of the interdisciplinary Diabetic Foot Conference (DFCon) will be held in San Francisco at the Marriot Marquis Conference Hotel. It will also be possible to attend virtually – as the program will also be livestreamed.

Each year, DFCon gathers influential speakers and delivers outstanding scientific content. DFCon will not only do that, it will also present new opportunities for networking and many participants and speakers who did not yet have the opportunity to experience DFCon previously due to travel and resource restrictions will get the chance now with DFCon. As always, the DFCon conference allows the best in their field to come together and learn from each other. DFCon also serves as a hands-on, dynamic congress where delegates can use the experience to immediately bring impact to their daily clinical practice. You will learn more about the different topics and sessions on the following pages.

There is a challenge facing us: redefining the role of a medical congress in the 21st century. The physician from twenty years ago is different from the physician of today. Knowledge is now available at their fingertips. The information is no longer an end in itself, it’s a conversation starter. DFCon exists to facilitate this meeting of physicians where ideas can be exchanged freely. DFCon is widely acknowledged as being a leader in discovery. Next-generation endovascular therapies, wearable robots, spray-on skin, sociomicrobiology, smart textiles, phage therapy, augmented reality and injectable sensors have all made their debut at DFCon.

The DFCon program is designed for the wide spectrum of generalists and specialists who diagnose and manage the diabetic foot. Didactic talks, panel discussions, Q&A sessions, specialty symposia and workshops will delve into diagnostics and interventional strategies for diabetic foot ulcers and amputation prevention.Featuring a world-renowned international faculty, DFCon offers the opportunity to review state-of-the-art concepts and techniques.

This is only the beginning.

DFCon is an opportunity to meet your customers, initiate new collaborations and find inspiration or even an investor. Your invaluable participation as a sponsor makes DFCon more accessible to delegates and provides you the opportunity to meet them in a setting away from the requirements of their demanding schedules. Throughout the years, DFCon has been recognized as the premier scientific and educational diabetic foot event, but our ambition goes beyond that. It is always the hope to cultivate the advancements of our field and continue to learn from each other.

We hope you will join us on this exciting journey.

David G. Armstrong DPM, MD, PhD

Keck School of Medicine of USC

Co-Founder & Co-Chair

1. Identify updated information to provide patient care in the discipline of limb preservation.
2. Explain new techniques in collaborating and communicating with teams to ensure best practices in patient care, education and research in limb preservation.
3. Apply quality improvement in areas of limb preservation. Utilize updated information as outlined in program as related to limb preservation diagnosis and diseases.
4. Outline new techniques and studies along with innovative approaches related to patient care, medical knowledge, practice-based learning and improvement, and system-based practices.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 14.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by October 6, 2021, 12:00 pm PDT, for a refund. In support of health care professionals' need for flexibility during COVID-19, cancellation fees are waived for a full refund. In the event of course cancellation by conference organizers, all registration fees will be fully refunded.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

David Armstrong, DPM

Faculty

Nothing to disclose

Martin Berli, MD

Faculty

Nothing to disclose

Marc Bonaca, MD, MPH

Faculty

Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-AstraZeneca|Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-Bayer Corporation|Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-Amgen|Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-ARCA BioPharma|Donation of study materials to CPC - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions.-Everlywell|Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-Janssen|Grant support to CPC, a non-profit ARO - Dr. Bonaca is the Executive Director of CPC, but does not receive direct contributions-NovoNordisk

Andrew J.M. Boulton, MD
Prof
University of Manchester
Manchester, United Kingdom

Faculty

Nothing to disclose

Leonardo C Clavijo, MD
KSOM-Keck School of Medicine
san luis obispo

Faculty

Nothing to disclose

Giacomo Clerici, MD
,

Faculty

Nothing to disclose

Michael S Conte, MD
Chief and Professor, Vascular Surgery
University of California, San Francisco
San Francisco, CA

Faculty

Advisory Board-Abbott Vascular|Grant-Profusa|Advisory Board-Anges

Ryan T Crews, PhD, CCRP
Associate Professor
Rosalind Franklin University of Medicine & Science
North Chicago, IL

Faculty

Nothing to disclose

Wuquan Deng, MD, PhD
Chinna
Chongqing, China, 00

Faculty

Nothing to disclose

Monara Dini, DPM
University of California San Francisco
San Francisco, CA

Faculty

Nothing to disclose

Foluso A Fakorede, MD
Cardiovascular Solutions of Central Ms/Fusion Vascular
Cleveland, MS

Faculty

Nothing to disclose

Roberto Ferraresi, MD
Director
Clinica San Carlo
Paderno Dugnano, Italy

Faculty

Consulting Fee-Limflow|Consulting Fee-Abbott Vascular|Consulting Fee-Asahi Intecc Co.|Consulting Fee-Biotronik, Inc.|Consulting Fee-Cardiva Medical, Inc.|Consulting Fee-Philips Medical Systems, Inc.

Brian D Lepow, DPM
HOPE Vascular & Podiatry
Houston, TX

Faculty

Consulting Fee-Bard Peripheral Vascular, Inc.|Consulting Fee-Medline|Consulting Fee-Limflow|Consulting Fee-Kent

Will Li, MD, PhD

Faculty

Nothing to disclose

Charles Y. Liu, MD, PhD
Keck School of Medicine of USC
Los Angeles, CA

Faculty

Nothing to disclose

Rayaz Malik, MD

Faculty

Nothing to disclose

John D Miller, DPM
Dr.
Foot and Ankle Surgeons of the Mid-Atlantic
Washington , DC

Faculty

Nothing to disclose

Joseph L Mills Sr. Sr., MD, FACS
Professor & Chief
Baylor College of Medicine
Houston, TX

Faculty

Nothing to disclose

Samantha D Minc, MD, MPH, FSVS, RPVI, FACS
Dr.
West Virginia University
Morgantown, WV

Faculty

Nothing to disclose

Miguel Montero-Baker, MD
Texas
Houston, TX

Faculty

Consulting Fee-Bard Peripheral Vascular, Inc.|Consulting Fee-Boston Scientific Corporation|Consulting Fee-Cook Group Incorporated

Bijan Najafi, PhD
Prof
UCLA
Houston, CA

Faculty

Consulting Fee-Biosensics LLC|Consulting Fee-Molnlyke |Consulting Fee-Takeda|Consulting Fee-Innovation Lab|Contracted Research-Results Group|Contracted Research-EO2 Concept|Contracted Research-Eden Inc

James Nduati, MPH, PUBLIC HEALTH DIABETES FOOT NURSE SPECIALIST
Mr.
D FOOT REP KENYA
nairobi

Faculty

Nothing to disclose

Erika Petersen, MD, FAANS, FACS
Professor
University of Arkansas for Medical Sciences
Little Rock, AR

Faculty

Consulting Fee-Abbott Laboratories|Consulting Fee-Nevro|Consulting Fee-Medtronic, Inc.|Consulting Fee-Vertos|Consulting Fee-Saluda|Contracted Research-Nevro|Contracted Research-Saluda|Ownership Interest-SynerFuse

Rodica Pop-Busui, MD
Oregon Health and Science University, OR

Faculty

Consulting Fee-Averitas Pharma|Consulting Fee-Novo Nordisk|Consulting Fee-Nevro

Sid Rao, MD
Dr.
Vascular Solutions of NC
Cary, NC

Faculty

Consulting Fee-Cardiovascular Systems, Inc|Consulting Fee-Philips Medical Systems, Inc.

Alexander M. Reyzelman, DPM, FACFAS
UCSF
San Francisco, CA

Faculty

Nothing to disclose

Lee C Rogers, DPM, FFPM RCPS(Glas.)
Prof.
University of Texas Health Science Center at San Antonio
San Antonio, CA

Faculty

Nothing to disclose

Vincent L Rowe, MD
KSOM-Keck School of Medicine
Los Angeles, CA

Faculty

Nothing to disclose

Haritha Samaranayake, MD, Medical Director, Aurealis Therapeutics
Aurealis Therapeutics
Kuopio, Finland

Faculty

Nothing to disclose

Marcos Schechter, MD
Emory University
Atlanta

Faculty

Nothing to disclose

Laura Shin, DPM, PhD
Assistant Professor of Clinical Surgery
Keck School of Medicine of USC
Glendora, CA

Faculty

Nothing to disclose

Ilker Uckay, MD

Faculty

Nothing to disclose

Shant Vartanian, MD

Faculty

Nothing to disclose

Max Wohlauer, MD

Faculty

Nothing to disclose